Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target | GenomeWeb

This article has been updated from a previous version to clarify the fact that Qiagen placed 750 QiaSymphony instruments as of the end of 2012, not that it placed 750 instruments during the year. It expects a total of 1,000 placements by the end of 2013, not a total of 1,000 instruments during the year.

NEW YORK (GenomeWeb News) — Qiagen today said that it has signed three agreements to expand its companion diagnostic development pipeline.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.